Wharton Business Group, LLC Pfizer Inc Transaction History

Wharton Business Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $491,997 - $729,303	11,907 New	11,907 $703,000
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $467,349 - $600,350	-11,907 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $4,889 - $5,514	146 Added 1.24%	11,907 $431,000
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $18,877 - $24,003	564 Added 5.04%	11,761 $433,000
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $61,468 - $72,116	1,936 Added 20.9%	11,197 $411,000
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $1,355 - $1,644	-45 Reduced 0.48%	9,261 $303,000
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $27,705 - $39,585	-1,025 Reduced 9.92%	9,306 $304,000
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $2,550 - $2,801	-68 Reduced 0.65%	10,331 $439,000
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $3,171 - $3,846	-92 Reduced 0.88%	10,399 $458,000
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $10,850 - $11,567	329 Added 3.24%	10,491 $380,000
Q1 2018 May 03, 2018	BUY	$31.91 - $37.02 $2,935 - $3,405	92 Added 0.91%	10,162 $361,000
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $312,170 - $343,890	10,070	10,070 $359,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Wharton Business Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Wharton Business Group, LLC with notifications on news.